These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39113661)

  • 1. Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart Transplantation.
    Huang X; Salerno D; Kovac D; Scheffert J; Hedvat J; Carver B; Choe J; Shertel T; Yuzefpolskaya M; Colombo PC; Jennings DL
    Clin Transplant; 2024 Aug; 38(8):e15420. PubMed ID: 39113661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation: 15-year analysis of recent UNOS database.
    El-Husseini A; Aghil A; Ramirez J; Sawaya B; Rajagopalan N; Baz M; Mei X; Davenport DL; Gedaly R
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28881060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Pediatric Kidney Transplantation in Recipients of a Previous Non-Renal Solid Organ Transplant.
    Hamdani G; Zhang B; Liu C; Goebel J; Zhang Y; Nehus E
    Am J Transplant; 2017 Jul; 17(7):1928-1934. PubMed ID: 28267897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era.
    Amin AA; Araj FG; Ariyamuthu VK; Drazner MH; Ayvaci MUS; Mammen PPA; Mete M; Urey MA; Tanriover B
    Clin Transplant; 2019 Aug; 33(8):e13651. PubMed ID: 31230375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
    Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
    PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from more than 1,000 pancreas transplants at a single institution.
    Sutherland DE; Gruessner RW; Dunn DL; Matas AJ; Humar A; Kandaswamy R; Mauer SM; Kennedy WR; Goetz FC; Robertson RP; Gruessner AC; Najarian JS
    Ann Surg; 2001 Apr; 233(4):463-501. PubMed ID: 11303130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes.
    Bittermann T; Hubbard RA; Lewis JD; Goldberg DS
    Am J Transplant; 2019 Dec; 19(12):3319-3327. PubMed ID: 31243887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting graft survival within 1-year post-transplantation in heart and lung transplant: an analysis of the OPTN/UNOS registry.
    Ohe H
    Clin Transpl; 2012; ():67-82. PubMed ID: 23721010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function.
    Ravindra KV; Sanoff S; Vikraman D; Zaaroura A; Nanavati A; Sudan D; Irish W
    Am J Transplant; 2019 Mar; 19(3):781-789. PubMed ID: 30171800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate.
    Yadav K; Serrano OK; Peterson KJ; Pruett TL; Kandaswamy R; Bangdiwala A; Ibrahim H; Israni A; Lake J; Chinnakotla S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29105843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor heart dysfunction and graft survival in liver and kidney transplants-A register-based study from Sweden.
    Svensson CJ; Öberg J; Dellgren G; Gäbel M; Oras J
    Clin Transplant; 2024 May; 38(5):e15333. PubMed ID: 38739219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction.
    Lange NW; Salerno DM; Sammons CM; Jesudian AB; Verna EC; Brown RS
    Clin Transplant; 2018 Dec; 32(12):e13415. PubMed ID: 30276862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression: practice and trends.
    Kaufman DB; Shapiro R; Lucey MR; Cherikh WS; T Bustami R; Dyke DB
    Am J Transplant; 2004; 4 Suppl 9():38-53. PubMed ID: 15113354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.